152 related articles for article (PubMed ID: 19074881)
1. Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effector.
Kim YC; Clark RJ; Ranheim EA; Alexander CM
Cancer Res; 2008 Dec; 68(24):10145-53. PubMed ID: 19074881
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
4. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.
Klauzinska M; Baljinnyam B; Raafat A; Rodriguez-Canales J; Strizzi L; Greer YE; Rubin JS; Callahan R
J Cell Physiol; 2012 May; 227(5):1960-71. PubMed ID: 21732367
[TBL] [Abstract][Full Text] [Related]
5. MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.
Teissedre B; Pinderhughes A; Incassati A; Hatsell SJ; Hiremath M; Cowin P
PLoS One; 2009; 4(2):e4537. PubMed ID: 19225568
[TBL] [Abstract][Full Text] [Related]
6. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation.
Howe LR; Watanabe O; Leonard J; Brown AM
Cancer Res; 2003 Apr; 63(8):1906-13. PubMed ID: 12702582
[TBL] [Abstract][Full Text] [Related]
7. Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.
Kumar R; Balasenthil S; Pakala SB; Rayala SK; Sahin AA; Ohshiro K
Cancer Res; 2010 Aug; 70(16):6598-608. PubMed ID: 20710043
[TBL] [Abstract][Full Text] [Related]
8. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.
Baker R; Kent CV; Silbermann RA; Hassell JA; Young LJ; Howe LR
PLoS One; 2010 Jan; 5(1):e8854. PubMed ID: 20107508
[TBL] [Abstract][Full Text] [Related]
9. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
10. Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1.
Li J; Dai Y; Zhu H; Jiang Y; Zhang S
Hum Reprod; 2016 Jun; 31(6):1224-35. PubMed ID: 27005891
[TBL] [Abstract][Full Text] [Related]
11. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
12. IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.
Rota LM; Albanito L; Shin ME; Goyeneche CL; Shushanov S; Gallagher EJ; LeRoith D; Lazzarino DA; Wood TL
Cancer Res; 2014 Oct; 74(19):5668-79. PubMed ID: 25092896
[TBL] [Abstract][Full Text] [Related]
13. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
14. Proteotypic classification of spontaneous and transgenic mammary neoplasms.
Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP
Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849
[TBL] [Abstract][Full Text] [Related]
15. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.
Li Y; Welm B; Podsypanina K; Huang S; Chamorro M; Zhang X; Rowlands T; Egeblad M; Cowin P; Werb Z; Tan LK; Rosen JM; Varmus HE
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15853-8. PubMed ID: 14668450
[TBL] [Abstract][Full Text] [Related]
16. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
17. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
19. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.
Guo X; Oshima H; Kitmura T; Taketo MM; Oshima M
J Biol Chem; 2008 Jul; 283(28):19864-71. PubMed ID: 18495668
[TBL] [Abstract][Full Text] [Related]
20. Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer.
Yeo EJ; Cassetta L; Qian BZ; Lewkowich I; Li JF; Stefater JA; Smith AN; Wiechmann LS; Wang Y; Pollard JW; Lang RA
Cancer Res; 2014 Jun; 74(11):2962-73. PubMed ID: 24638982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
